Chengdu Easton Biopharmaceuticals Co (SHSE:688513) 3-Year Book Growth Rate : 7.50% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co 3-Year Book Growth Rate?

Chengdu Easton Biopharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥21.87.

During the past 12 months, Chengdu Easton Biopharmaceuticals Co's average Book Value per Share Growth Rate was 4.80% per year. During the past 3 years, the average Book Value per Share Growth Rate was 7.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 29.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 8 years, the highest 3-Year average Book Value per Share Growth Rate of Chengdu Easton Biopharmaceuticals Co was 52.20% per year. The lowest was 7.50% per year. And the median was 38.00% per year.

Competitive Comparison of Chengdu Easton Biopharmaceuticals Co's 3-Year Book Growth Rate

For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chengdu Easton Biopharmaceuticals Co's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Easton Biopharmaceuticals Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's 3-Year Book Growth Rate falls into.

Chengdu Easton Biopharmaceuticals Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Chengdu Easton Biopharmaceuticals Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731

Website

http://www.eastonpharma.cn

Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Headlines

No Headlines